Search research articles
Contact Us
Filters
Showing results (181-190 of 290) with videos related to
Page
of 29
Sort By:
Journal of Clinical Pathology
|
April 1, 1976
Clinical and laboratory studies into the pathogenesis of malacoplakia
K J Lewin, W R Fair, R T Steigbigel, et al.
Urology
|
April 11, 2001
Dietary trial in prostate cancer: Early experience and implications for clinical trial design
D M Ornish, K L Lee, W R Fair, et al.
The Journal of Urology
|
March 1, 1986
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection
H W Herr, W F Whitmore, P C Sogani, et al.
The Journal of Urology
|
June 1, 1987
Flow cytometric analysis of primary adenocarcinoma of the bladder
R A Badalament, E S Cibas, V E Reuter, et al.
The Journal of Urology
|
December 1, 1988
Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
D K Hermansen, V E Reuter, W F Whitmore, et al.
Clinical Chemistry
|
October 1, 1992
Abbott IMx evaluated for assay of prostate-specific antigen in serum
A M Dnistrian, M K Schwartz, C A Smith, et al.
Cancer Research
|
December 15, 1990
DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage
P R Bretton, Z Darzynkiewicz, E Henry, et al.
The Journal of Urology
|
May 1, 1980
Three-day treatment of urinary tract infections
W R Fair, D B Crane, L J Peterson, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells
S M Donat, C T Powell, R S Israeli, et al.
Seminars in Surgical Oncology
|
September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumors
G Dalbagni, V E Reuter, J Sheinfeld, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 290) with videos related to
Sort By:
Page
of 29
Journal of Clinical Pathology
|
April 1, 1976
Clinical and laboratory studies into the pathogenesis of malacoplakia
K J Lewin, W R Fair, R T Steigbigel, et al.
Urology
|
April 11, 2001
Dietary trial in prostate cancer: Early experience and implications for clinical trial design
D M Ornish, K L Lee, W R Fair, et al.
The Journal of Urology
|
March 1, 1986
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection
H W Herr, W F Whitmore, P C Sogani, et al.
The Journal of Urology
|
June 1, 1987
Flow cytometric analysis of primary adenocarcinoma of the bladder
R A Badalament, E S Cibas, V E Reuter, et al.
The Journal of Urology
|
December 1, 1988
Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
D K Hermansen, V E Reuter, W F Whitmore, et al.
Clinical Chemistry
|
October 1, 1992
Abbott IMx evaluated for assay of prostate-specific antigen in serum
A M Dnistrian, M K Schwartz, C A Smith, et al.
Cancer Research
|
December 15, 1990
DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage
P R Bretton, Z Darzynkiewicz, E Henry, et al.
The Journal of Urology
|
May 1, 1980
Three-day treatment of urinary tract infections
W R Fair, D B Crane, L J Peterson, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells
S M Donat, C T Powell, R S Israeli, et al.
Seminars in Surgical Oncology
|
September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumors
G Dalbagni, V E Reuter, J Sheinfeld, et al.
Page
of 29